🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Day 2 at the Case Microbiome Workshop Case Comp Cancer Ctr. CWRU student David Hoying did an amazing job sharing our work on intratumoral microbiome in larynx cancer. This future ENT surgeon is one to watch.

Congrats Dr. Ku and team on this important work.

Travis Kerr is up first at #TRCCC2025, great job showing exciting data in HPV positive HNSCC and intratumoral bacteria.

Continuing the takeover from the Silver/McGrail lab in the Innate Immunity and Microbiota room #TRCCC Nandini Rajaram Siva and Subha Singh Case Comp Cancer Ctr CLEImmunoUpdate @CleClinicLCM

Case CCC scientists and students having a great time at the TRCCC meeting in Seven Springs, PA!

Honored to be able to share some of my work supported by Velosano. Cleveland Clinic Otolaryngology-Head/Neck Surgery

Newsweek has ranked Cleveland Clinic as the #2 hospital in the world. This recognition is a reflection of our caregivers, who form the heart and soul of our organization. Their dedication to excellence and compassion are the pillars of our care. More: bit.ly/43n8n05

Was great to be able to present our research at the LRI Spotlight Seminar. Thanks to all that attended!

So proud of @rahika_duggal @CleClinicLCM Cleveland Clinic Otolaryngology-Head/Neck Surgery who matched to the CCF Otolaryngology program! So glad to continue to work with you for the next 5 years. You are a rock ⭐ and we are so fortunate to have you! Can't wait to see the amazing surgeon scientist you will become!

🚨Finally! Ravi Uppaluri, MDPhD presents data from Keynote0689 -- anti-PD1 makes it in locally advanced HNSCC -- approximate 10% EFS benefit from Pembro in surgically managed HNSCC. #aacr25 #hncsm

Excited for the upcoming conference. Come join us! Cleveland Clinic Otolaryngology-Head/Neck Surgery CLEImmunoUpdate

Thank you Dr. Alfredo Quiñones-Hinojosa and program organizers for allowing me to share our translational work in therapeutic RNA vaccines for cancer at the Mayo Clinic RNA Discoveries and Therapeutics Conference 2025. What an exciting and inspiring few days it has been! Cleveland Clinic Otolaryngology-Head/Neck Surgery

Amazing talk this am by Dr Natalie Silver MD, MS, FACS-DrSilverLab Inspiring surgeon Extraordinary surgeon scientist Powerful hope Mayo Clinic Cleveland Clinic Building bridges FLORIDA Nilufer Ertekin-Taner, MD, PhD Cheryl Willman, M.D. Vijay Shah J. Emiliano Sanchez-Garavito M.D.

“Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib should be considered a new standard of care for Stage IV BRAF V600E-mutated anaplastic thyroid cancer,” says our Mark Zafereo, MD at #ASCO25. Read more about this practice-changing research:

How should TORS be used in HPV-positive oropharyngeal cancer? Dr. Jamie Ku walks through the new ASCO guidelines and highlights key criteria for patient selection on the latest Cleveland Clinic MD Cancer Advances episode. #CleClinicCancer cle.clinic/3ZRrDQq

An infographic presented by the AHNS Basic and Translational Science Service The promise and uncertainties of applying the new neoadjuvant anti-PD1 standard created by KEYNOTE-689 #AHNS #neoadjuvant #immunotherapy #HNSCC

FDA approves pembrolizumab for resectable, locally advanced HNSCC based on KEYNOTE‑689. Led by Dr. Ravindra Uppaluri Ravi Uppaluri, MDPhD, the study showed a 30% drop in recurrence risk. Full details from The ASCO Post: ascopost.com/news/june-2025… #HNSCC #Oncology

It is wonderful to be part of one of the cancer hospitals in the world as per ⁦Newsweek⁩ rankings.newsweek.com/americas-best-…